hypercholesterolaemia. Goldstein and Brown's concept of familial hypercholesterolaemia as a group of disorders characterised by deficiencies or abnormalities of LDL receptors does not provide an obvious explanation.13 Also if the entire arterial tree and all tissues in all the homozygotes are exposed from an early age to the extremely unfavourable combination of very high concentrations of atherogenic LDL and distinctly low concentrations of anti-atherogenic HDL, how do we explain the variable natural history, the dissociation in severity between the arterial and cutaneous lesions, and the striking predominance of coronary artery disease clinically ? Possible explanations include genetic heterogeneity, interactions with other risk factors for arterial disease, and, perhaps most important, the reactivity of the tissues. 7 occlusion and angina. More recent reports3-8 would appear to support this observation, but nobody has carried out a prospective detailed examination of vomiting in the various acute ischaemic cardiac syndromes, although some attempt has been made to identify the role of narcotic drugs in this respect. If there were a significant difference in the incidence of vomiting between acute myocardial infarction and other forms ofischaemic cardiac pain before the administration of analgesics, this would be a useful diagnostic pointer during the initial clinical assessment in general practice and in accident and emergency departments, whose medical staff are often the first to encounter such patients.
The stimulus to vomiting during myocardial ischaemia remains uncertain in man but may be analogous to the van Bezold-Jarisch reflex, which has been extensively studied in experimental animals. 6 7 This reflex is mediated through afferent fibres arising in the heart "substance" and travels in the vagus nerve.5-7 Since autonomic instability is a common early feature of myocardial infarction, vomiting induced via this pathway might be expected to be associated with other evidence of vagal activity-for example, sinus bradycardia, sweating, and hypotension. Other factors previously thought to be related to vomiting include the site6 and size8 of infarction. We carried out a study in which we investigated the incidence of vomiting in various acute ischaemic cardiac syndromes and the relation of the above factors to vomiting.
Patients and methods
One hundred and nine consecutive patients admitted to the coronary monitoring unit of this hospital with acute ischaemic myocardial pain were allocated into three groups: those with proved transmural myocardial infarction (58 patients), those with myocardial 12 hours, heart rate on admission, the presence or absence of sweating and nausea, and the development of pericarditis were also recorded. The site of infarction and the peak activity of serum aspartate transaminase were added to each set of data.
Data were analysed for significance of differences using paired Student's t tests.
Results
Twenty-five (43°h) of the 58 patients with proved acute myocardial infarction vomited before they received analgesic drugs. The remainder (57 %) with proved infarctions did not vomit, but 17 of them (50 %) experienced nausea. Only one (4 3 %) ofthe 23 patients with myocardial necrosis and one (3 6 %) with acute coronary insufficiency vomited. Seven (30 %) with myocardial necrosis and nine (32 %) with coronary insufficiency suffered nausea. The difference in the incidence of vomiting after acute myocardial infarction when compared with that in the other two groups of patients is highly significant (p<0 001).
Patients who had experienced anterior infarction were more likely to vomit than those who had experienced inferior infarction (p < 0 05). No significant relation was found between the incidence of vomiting and the size of recent infarction (peak activity of serum aspartate transaminase), the development of pericarditis, or a history of coronary heart disease or gastrointestinal symptoms (table). Likewise, no correlation was found between vomiting and previous smoking habits or drug treatment (in particular beta-blockade and treatment with digoxin).
Only two patients in the series had systolic blood pressures of less than 100 mm Hg, and none had a profound bradycardia (heart rate <50/minute).
Discussion
The reported incidence of vomiting associated with the acute phase of myocardial infarction varies between 28% and 59%. [3] [4] [5] In these studies, however, only scant attention was given to prior treatment with narcotic or analgesic drugs, or both, or digoxin. Our study yielded an incidence of vomiting of 43%. This closely approaches Bean's figures3 when they are corrected to take account of patients who had received morphine or large doses of digitalis. Wright,5 on the other hand, found no significant difference between treated (unspecified) and control groups, the incidence of vomiting being: 29% and 31% respectively.
In the present study only two patients in the non-infarction (necrosis and insufficiency) groups vomited. This finding is highly significant (p <0-001) and means that when early spontaneous vomiting is associated with acute ischaemic cardiac pain over 90% of such patients have sustained transmural myocardial infarction.
Oram8 suggested that vomiting is more commonly associated with "large" infarcts. Our data, with the peak serum activity of aspartate transaminase being used as an index of infarct size, failed to support this observation.
Vomiting has been thought to be particularly associated with inferior myocardial infarction.6 7 A recent study by Darseell showed that the desire to belch (labelled "eructoneogenesis" and assumed to be vagally mediated "gastric distress") in association with cardiac pain due to coronary disease "always indicated inferior-wall myocardial infarction," this symptom being absent in anterior infarction. Our study, however, shows that 58% of patients with anterior infarction vomit compared with only 29% of patients with inferior infarcts; of all patients who vomited, 60% had sustained anterior infarction. These findings are significant (p <005), and therefore we question Darsee's observation.
Preceding ischaemic heart disease does not seem to protect patients from vomiting during infarction. This observation is supported by Bean's finding3 that the incidence of vomiting is the same during first and second infarctions. Likewise, no association between smoking and vomiting was found. Treatment with beta-blockers before infarction does not lessen the stimulus to vomiting during infarction.
Although our findings fail to explain the cause of vomiting after myocardial infarction, the clear-cut relation with transmural necrosis suggests that the vomiting reflex, if such exists, might arise as a consequence of damage to the subpericardial tissue.
